Sign up to recieve our quarterly print newsletter, The Beat.
NATF is striving to reach our 2016 Annual Fund goal, and we're almost there.
Go here to support NATF and help us reach our goal of $250,000.
April 20-22, 2017
Los Angeles, CA
Early Bird Registration Ends December 15
3-Day symposium will bring together medical professionals in fields ranging from cardiology and hematology to pharmacy and family medicine for discussions on current research and evidence-based practices in the field of antithrombotic therapy. In addition to presentations by leading experts, the conference will feature small, topic-specific master classes, a "meet the expert" breakfast, poster sessions and industry exhibits.
For more information and to register, visit acforum2017.org
Offering patients the chance to ask questions, share common concerns, support one another, and learn up-to-date and accurate information about VTE. In upcoming months, we will have alternating physicians serving as moderators for group, each with their own perspective.
Upcoming Support Group Dates:
Wednesday, January 18 - Dr. Geoffrey Barnes
SIGN UP NOW to receive information on how to join a support group.
For this program, entitled 'Pushing the Envelope in Cardiovascular Disease Prevention: Novel Risk Factors, New Therapies, and One Brave Idea', four experts in the field of Thrombosis Medicine will share updates including innovative ways to prevent and treat diabetes and metabolic syndrome, whether a simple blood test can predict your risk of developing cardiovascular disease, new medications to lower cholesterol, and a glimpse into the largest ever research project to cure heart disease.
The jury is in on inflammation. The verdict? Inflammation has been found guilty of causing thrombosis in patients — See More
"What determines what part of the body gets a blood clot? Why do some blood clots go to the heart, whereas others go to the brain or to the pulmonary arteries?" Dr. Aaron W. Aday weighs in – See More
Dr. Aaron Kithcart has the answers – See More
For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants. View the Chart.